Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

If you are merely speaking about the current p/s, that is correct. Yet, it remains that looking in the rear view mirror does not tell you the road ahead; such as it is in business when strategies are all about adaptiveness. Kind of like moving to CNS ANDAs when the socio-political environment is pressing opioids.

Moreover, Elite is generating recurring revenues. What about that? I think that is worthy of discussion. In fact, that is what will lead to success. Does that mean $2.10 p/s? Who knows. But it will be exponentially higher than 5 cents.